HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide
0.1.0 - CI Build

HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide, published by Te Aho o Te Kahu, Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7NZ/cca/ and changes regularly. See the Directory of published versions

## : Colorectal Adjuvant FOLFOX (a7) - XML Representation

Active as of 2020-06-29

Raw xml | Download

    <PlanDefinition xmlns="http://hl7.org/fhir">
      <id value="ColoRectal"/>
      <meta>
        <profile
                 value="http://hl7.org.nz/fhir/StructureDefinition/CcaPlanDefinition"/>
      </meta>
      <text>
        <status value="additional"/>
        <div xmlns="http://www.w3.org/1999/xhtml">Plan for ColoRectal cancer. There is a single cycle with 2 drug administrations</div>
      </text>
      <contained>
        <ActivityDefinition>
          <id value="ActTragacanth"/>
          <meta>
            <profile
                     value="http://hl7.org.nz/fhir/StructureDefinition/CcaActivityDefinition"/>
          </meta>
          <text>
            <status value="additional"/>
            <div xmlns="http://www.w3.org/1999/xhtml">Tragacanth administration, 3mg over 3 hours by continuous IV infusion</div>
          </text>
          <status value="draft"/>
          <productCodeableConcept>
            <coding>
              <system value="https://nzulm.org.nz/nzmt"/>
              <code value="10711851000116105"/>
              <display value="Tragacanth"/>
            </coding>
          </productCodeableConcept>
          <dosage>
            <text value="3 mg over 3 hours by IV infusion"/>
            <route>
              <coding>
                <system value="http://snomed.info/sct"/>
                <code value="180177004"/>
                <display value="continuous intravenous infusion"/>
              </coding>
            </route>
            <doseAndRate>
              <doseQuantity>
                <value value="3"/>
                <system value="http://unitsofmeasure.org"/>
                <code value="mg"/>
              </doseQuantity>
              <rateQuantity>
                <value value="3"/>
                <system value="http://unitsofmeasure.org"/>
                <code value="h"/>
              </rateQuantity>
            </doseAndRate>
          </dosage>
        </ActivityDefinition>
      </contained>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions">
        <valueMarkdown value="Only for women"/>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-disclaimer">
        <valueMarkdown value="Developed with the best of intentions."/>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-regimen-type">
        <valueCodeableConcept>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="dummy"/>
          </coding>
          <text value="Folfox"/>
        </valueCodeableConcept>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor">
        <extension url="factor">
          <valueCodeableConcept>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="TOUPDATE-SUPPORT4"/>
              <display value="Diarrhoea risk"/>
            </coding>
          </valueCodeableConcept>
        </extension>
        <extension url="value">
          <valueCodeableConcept>
            <text value="low"/>
          </valueCodeableConcept>
        </extension>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor">
        <extension url="factor">
          <valueCodeableConcept>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="TOUPDATE-SUPPORT8"/>
              <display value="AntiFungal Prophylaxis"/>
            </coding>
          </valueCodeableConcept>
        </extension>
        <extension url="value">
          <valueCodeableConcept>
            <text value="low"/>
          </valueCodeableConcept>
        </extension>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor">
        <extension url="factor">
          <valueCodeableConcept>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="TOUPDATE-SUPPORT2"/>
              <display value="Hypersensitivity / Infusion related reaction ris"/>
            </coding>
          </valueCodeableConcept>
        </extension>
        <extension url="value">
          <valueCodeableConcept>
            <text value="low"/>
          </valueCodeableConcept>
        </extension>
      </extension>
      <url value="http://hl7.org.nz/fhir/ig/cca/PlanDefinition/ColoRectal"/>
      <version value="0.1.0"/>
      <title value="Colorectal Adjuvant FOLFOX (a7)"/>
      <type>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
          <code value="clinical-protocol"/>
        </coding>
      </type>
      <status value="active">
        <extension
                   url="http://hl7.org.nz/fhir/StructureDefinition/sact-additional-plan-status">
          <valueCode value="review"/>
        </extension>
      </status>
      <experimental value="false"/>
      <date value="2020-06-29T20:14:18.417+12:00"/>
      <publisher value="Te Aho o Te Kahu, Cancer Control Agency"/>
      <description
                   value="A drug treatment regimen for Colorectal cancer. Plan is still under review."/>
      <useContext>
        <code>
          <system
                  value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
          <code value="focus"/>
        </code>
        <valueCodeableConcept>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="781382000"/>
            <display value="Colorectal cancer"/>
          </coding>
        </valueCodeableConcept>
      </useContext>
      <relatedArtifact>
        <type value="citation"/>
        <display value="test"/>
        <url value="http://www.ncbi.nlm.nih.gov/pubmed/23434"/>
        <document>
          <url value="http://www.ncbi.nlm.nih.gov/pubmed/23434"/>
        </document>
      </relatedArtifact>
      <relatedArtifact>
        <type value="citation"/>
        <display value="test2"/>
        <url value="http://www.ncbi.nlm.nih.gov/pubmed/34324"/>
        <document>
          <url value="http://www.ncbi.nlm.nih.gov/pubmed/34324"/>
        </document>
      </relatedArtifact>
      <action>
        <extension
                   url="http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions">
          <valueMarkdown value="Ensure not pregnant before starting"/>
        </extension>
        <title value="This is the only cycle in the regimen."/>
        <description
                     value="Administration of Cabergoline and Tragacanth. Cycle length 14 days"/>
        <timingTiming>
          <repeat>
            <count value="1"/>
            <duration value="14"/>
            <durationUnit value="d"/>
          </repeat>
        </timingTiming>
        <selectionBehavior value="all"/>
        <action>
          <extension
                     url="http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions">
            <valueMarkdown value="Keep a close eye for side effects"/>
          </extension>
          <extension
                     url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
            <extension url="day">
              <valueInteger value="1"/>
            </extension>
            <extension url="instructions">
              <valueString
                           value="Specific instructions for the day 1 administration"/>
            </extension>
          </extension>
          <extension
                     url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
            <extension url="day">
              <valueInteger value="4"/>
            </extension>
            <extension url="instructions">
              <valueString
                           value="Specific instructions for the day 4 administration"/>
            </extension>
          </extension>
          <description
                       value="2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes"/>
          <definitionCanonical value="#act-cabergoline"/>
        </action>
        <action>
          <extension
                     url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
            <extension url="day">
              <valueInteger value="2"/>
            </extension>
            <extension url="instructions">
              <valueString
                           value="Specific instructions for the day 2 administration"/>
            </extension>
          </extension>
          <extension
                     url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
            <extension url="day">
              <valueInteger value="3"/>
            </extension>
            <extension url="instructions">
              <valueString
                           value="Specific instructions for the day 3 administration"/>
            </extension>
          </extension>
          <extension
                     url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
            <extension url="day">
              <valueInteger value="4"/>
            </extension>
            <extension url="instructions">
              <valueString
                           value="Specific instructions for the day 4 administration"/>
            </extension>
          </extension>
          <description
                       value="3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours"/>
          <definitionCanonical value="#act-tragacanth"/>
        </action>
      </action>
    </PlanDefinition>